Imagion Biosystems Limited
IBXXF
$0.01
-$0.02-66.67%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 65.89% | 77.71% | 83.63% | 66.05% | 47.70% |
| Total Depreciation and Amortization | -98.77% | -81.32% | -67.16% | -42.64% | -18.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -209.96% | -132.04% | -65.02% | -53.08% | -44.90% |
| Change in Net Operating Assets | -95.14% | -95.14% | -95.14% | 5.91% | 7,167.84% |
| Cash from Operations | -16.17% | 62.24% | 84.93% | 79.22% | 74.39% |
| Capital Expenditure | -- | -- | -- | 67.96% | 50.09% |
| Sale of Property, Plant, and Equipment | -100.00% | 0.36% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 130.87% | 144.12% | 100.41% | 75.32% |
| Total Debt Issued | -59.02% | -74.15% | -79.43% | -67.67% | -51.20% |
| Total Debt Repaid | 89.80% | 93.81% | 95.55% | 78.74% | 65.39% |
| Issuance of Common Stock | 58.64% | 43.59% | 31.15% | 82.05% | 373.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 30.51% | 57.09% | 68.96% | 51.26% | 19.26% |
| Cash from Financing | 37.66% | 3.70% | -16.28% | 6.99% | 77.90% |
| Foreign Exchange rate Adjustments | 111.39% | 184.62% | 742.86% | -101.71% | -111.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 929.76% | 170.11% | 156.73% | 119.33% | 99.16% |